| Ticker Details |
|
Instil Bio, Inc.
|
| IPO Date: |
March 19, 2021 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$57.48M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.67 | 4.24%
|
| Avg Daily Range (30 D): |
$0.20 | 2.41%
|
| Avg Daily Range (90 D): |
$0.23 | 2.55%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.3M |
| Avg Daily Volume (30 D): |
.02M |
| Avg Daily Volume (90 D): |
.08M |
| Trade Size |
| Avg Trade Size (Sh.): |
104 |
| Avg Trade Size (Sh.) (30 D): |
54 |
| Avg Trade Size (Sh.) (90 D): |
92 |
| Institutional Trades |
| Total Institutional Trades: |
192 |
| Avg Institutional Trade: |
$2.21M |
| Avg Institutional Trade (30 D): |
$1.01M |
| Avg Institutional Trade (90 D): |
$1.01M |
| Avg Institutional Trade Volume: |
.02M |
| Avg Institutional Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$5.85M |
| Avg Closing Trade (30 D): |
$.58M |
| Avg Closing Trade (90 D): |
$.58M |
| Avg Closing Volume: |
36.19K |
|
|
| Financials |
| |
TTM |
Q4 2025 |
FY 2025 |
|
Basic EPS
|
$-10.7
|
$-1.17
|
$-10.7
|
|
Diluted EPS
|
$-10.7
|
$-1.17
|
$-10.7
|
|
Revenue
|
$M
|
$M
|
$M
|
|
Gross Profit
|
|
|
|
|
Net Income / Loss
|
$-71.37M
|
$-8.19M
|
$-71.37M
|
|
Operating Income / Loss
|
$-78.58M
|
$-9.56M
|
$-78.58M
|
|
Cost of Revenue
|
|
|
|
|
Net Cash Flow
|
$-3.83M
|
$.72M
|
$-3.83M
|
|
PE Ratio
|
|
|
|
|
|
|
